• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2400136 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs License Renew 2024-05-24 Viatris Pharmaceuticals Co Ltd;Viatris Pharma GmbH;Pfizer Ireland Pharmaceuticals view
JYHZ2400135 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs License Renew 2024-05-24 Viatris Pharmaceuticals Co Ltd;Viatris Pharma GmbH;Pfizer Ireland Pharmaceuticals view
CYHS2302874 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs(4) Generic Drug 2023-10-24 Hunan Jiudian Pharmaceutical Co Ltd view
JYHB2300359 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2023-06-27 Viatris Pharma GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2300360 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2023-06-27 Viatris Pharma GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2200338 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2022-07-02 Pfizer OFG Germany GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2200339 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2022-07-02 Pfizer OFG Germany GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2101597 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2021-12-17 Pfizer OFG Germany GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2101598 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2021-12-17 Pfizer OFG Germany GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2101110 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2021-05-20 Pfizer OFG Germany GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2101108 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2021-05-20 Pfizer OFG Germany GmbH;Pfizer Ireland Pharmaceuticals view
JYHB2001364 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-08-21 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Ireland Pharmaceuticals;Pfizer Pharma Pfe GmbH Filed 2020-09-09 view
JYHB2001365 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-08-21 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Ireland Pharmaceuticals;Pfizer Pharma Pfe GmbH Filed 2020-09-09 view
JYHB2001097 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-07-06 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Ireland Pharmaceuticals;Pfizer Pharma Pfe GmbH Certificate Issued 2020-09-02 view
JYHB2001098 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-07-06 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Ireland Pharmaceuticals;Pfizer Pharma Pfe GmbH Certificate Issued 2020-09-02 view
JYHB2000013 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-01-09 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Australia Pty Ltd Filed 2020-01-17 view
JYHB2000016 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-01-09 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Australia Pty Ltd Filed 2020-01-17 view
JYHB2000015 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-01-09 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Australia Pty Ltd Filed 2020-01-17 view
JYHB2000014 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs Supplementary Application 2020-01-09 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Australia Pty Ltd Filed 2020-01-17 view
JXHL1900181 盐酸齐拉西酮胶囊 ziprasidone hydrochloride Capsule Chemical Drugs(5.1) Import Drug Application 2019-08-07 辉瑞制药有限公司 Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Pharma Pfe GmbH In Review 2019-08-06 view